ici 118551 and Disease Models, Animal

Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzofurans; Carrageenan; Disease Models, Animal; Drug Design; Drug Evaluation, Preclinical; Humans; Hyperalgesia; Ligands; Mice; Molecular Structure; Pain; Peritonitis; Quinazolines; Rats; Receptors, G-Protein-Coupled; Receptors, Histamine; Receptors, Histamine H4; Stereoisomerism; Structure-Activity Relationship

Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection

Topics: Amino Alcohols; Animals; Anticonvulsants; Crystallography, X-Ray; Disease Models, Animal; Dose-Response Relationship, Drug; Electroshock; Mice; Models, Molecular; Molecular Structure; Rats; Seizures; Structure-Activity Relationship

Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-2 Receptor Antagonists; Anaphylaxis; Animals; Atenolol; Coronary Vasospasm; Coronary Vessels; Disease Models, Animal; Isolated Heart Preparation; Male; Myocardial Contraction; Ovalbumin; Propanolamines; Rats, Wistar; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Time Factors; Vasoconstriction; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Pressure

Topics: Analysis of Variance; Animals; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Atenolol; Bradykinin; Bradykinin B1 Receptor Antagonists; Creatine Kinase; Dexamethasone; Disease Models, Animal; Electric Stimulation; Hyperalgesia; L-Lactate Dehydrogenase; Locomotion; Male; Muscle Contraction; Myalgia; Neutrophils; Propanolamines; Prostaglandins; Rats; Rats, Wistar

Topics: Aminophylline; Animals; Blood Pressure; Bronchodilator Agents; Cyclic AMP; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Epithelial Sodium Channels; Female; Heart Rate; Imidazoles; Iodine Radioisotopes; Iodocyanopindolol; Lung Injury; Male; Propanolamines; Protein Binding; Pulmonary Alveoli; Pulmonary Edema; Receptors, Adrenergic, beta-2; Reperfusion Injury; RNA, Messenger

Topics: Adrenergic beta-2 Receptor Antagonists; Alzheimer Disease; Amyloid beta-Peptides; Animals; Cerebral Cortex; Cognition; Disease Models, Animal; Disease Progression; Female; Hippocampus; Male; Mice, Transgenic; Phosphorylation; Propanolamines; Receptors, Adrenergic, beta-2; tau Proteins

Topics: Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Disease Models, Animal; HSP72 Heat-Shock Proteins; Infarction, Middle Cerebral Artery; Ischemic Attack, Transient; Male; Mice; Mice, Knockout; Motor Activity; Neuroprotective Agents; Propanolamines; Receptors, Adrenergic, beta-2; Up-Regulation

Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Functional Laterality; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Naltrexone; Narcotic Antagonists; Pain Measurement; Pain Threshold; Propanolamines; Receptors, Adrenergic, beta-2; Sciatica; Time Factors

Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Disease Models, Animal; Drug Administration Schedule; Male; Mice; Mice, Inbred C57BL; Neuralgia; Pain Measurement; Propanolamines; Propranolol

Topics: Acute Disease; Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Alzheimer Disease; Amyloid beta-Peptides; Animals; Clenbuterol; Disease Models, Animal; Hippocampus; Male; Mice; Mice, Inbred C57BL; Peptide Fragments; Propanolamines; Proto-Oncogene Proteins c-fos; Random Allocation; Receptors, Adrenergic, beta-2; Restraint, Physical; RNA, Messenger; Stress, Psychological

Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Disease Models, Animal; Enzyme Inhibitors; Epinephrine; Female; G-Protein-Coupled Receptor Kinase 2; Ganglia, Spinal; Gene Expression Regulation; Hyperalgesia; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neuroglia; Pain Measurement; Pain Threshold; Phentolamine; Propanolamines; Sensory Receptor Cells; Signal Transduction

Topics: Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Antagonists; Angiogenesis Inhibitors; Animals; Animals, Newborn; Atenolol; Cyclic AMP-Dependent Protein Kinases; Disease Models, Animal; Dose-Response Relationship, Drug; Electroretinography; Enzyme-Linked Immunosorbent Assay; Female; Gene Expression Regulation, Developmental; Humans; Infant, Newborn; Insulin-Like Growth Factor I; Male; Mice; Mice, Inbred C57BL; Organ Culture Techniques; Oxygen; Platelet Endothelial Cell Adhesion Molecule-1; Propanolamines; Receptors, Adrenergic, beta-2; Retinal Neovascularization; Retinopathy of Prematurity; RNA, Messenger; RNA, Small Interfering; Statistics, Nonparametric; Transfection; Vascular Endothelial Growth Factor A

Topics: Adrenergic beta-Antagonists; Animals; Apoptosis; bcl-Associated Death Protein; Cell Line, Tumor; Disease Models, Animal; Epinephrine; Humans; Hypothalamo-Hypophyseal System; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Pituitary-Adrenal System; Propanolamines; Prostatic Neoplasms; Proto-Oncogene Proteins c-myc; PTEN Phosphohydrolase; Receptors, Adrenergic, beta-2; Signal Transduction; Stress, Psychological; Transplantation, Heterologous

Topics: Adrenergic beta-Antagonists; Animals; Antibodies; Atenolol; Bone Marrow; Cell Differentiation; Cytokines; Disease Models, Animal; Drug Interactions; Endotoxins; Enzyme-Linked Immunosorbent Assay; Epinephrine; Interleukin-10; Laparotomy; Lipopolysaccharides; Macrophage Activation; Macrophages; Male; Mice; Myeloid Progenitor Cells; Propanolamines; Random Allocation; Sepsis

Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Consciousness; Disease Models, Animal; Drug Interactions; Endotoxemia; Lipopolysaccharides; Male; Piperidines; Propanolamines; Propranolol; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptors, Adrenergic, beta; Sympathetic Nervous System; Tachycardia; Vasodilation

Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-2 Receptor Antagonists; Albuterol; Animals; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Heart; Heat-Shock Proteins; Heme Oxygenase (Decyclizing); Inflammation; Lipopolysaccharides; Liver; Lung; Male; Myocardium; Nitric Oxide Synthase Type II; Propanolamines; Rats; Rats, Sprague-Dawley; RNA, Messenger

Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic alpha-Agonists; Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Disease Models, Animal; Lipopolysaccharides; Medetomidine; Propanolamines; Quinolines; Rats; Rats, Inbred Lew; Receptors, Adrenergic; Receptors, Adrenergic, alpha-2; Receptors, Adrenergic, beta-2; Receptors, Dopamine D1; Receptors, Dopamine D2; Serotonin 5-HT1 Receptor Antagonists; Serotonin Receptor Agonists; Tumor Necrosis Factor-alpha; Uveitis

Topics: Administration, Oral; Adrenergic beta-Antagonists; Animals; Asthma; Disease Models, Animal; Female; Inflammation; Infusion Pumps; Injections, Intraperitoneal; Ligands; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mucins; Nadolol; Ovalbumin; Propanolamines; Specific Pathogen-Free Organisms

Topics: Administration, Oral; Adrenergic beta-Antagonists; Animals; Asthma; Bronchoalveolar Lavage Fluid; Cytokines; Disease Models, Animal; Infusion Pumps; Injections, Intraperitoneal; Mice; Mucins; Nadolol; Ovalbumin; Propanolamines; Reproducibility of Results

Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Calcium; Cells, Cultured; Disease Models, Animal; Ethanolamines; Female; Heart Failure; Heart Ventricles; Humans; Male; Myocytes, Cardiac; Patch-Clamp Techniques; Phosphorylation; Propanolamines; Rabbits; Receptors, Adrenergic, beta-2; Sarcoplasmic Reticulum

Topics: Adrenergic beta-Antagonists; Animals; Anxiety; Betaxolol; Conflict, Psychological; Disease Models, Animal; Drug Interactions; Male; p-Chloroamphetamine; Pindolol; Piperazines; Prazosin; Propanolamines; Rats; Rats, Wistar; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Antagonists

Topics: Adenylyl Cyclases; Adipose Tissue; Adipose Tissue, Brown; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Base Sequence; Cells, Cultured; Cyclic AMP; Diabetes Mellitus, Type 2; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Activation; Epinephrine; Gene Expression Regulation; Hyperglycemia; Imidazoles; Lipolysis; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Molecular Sequence Data; Obesity; Propanolamines; Propranolol; Receptors, Adrenergic, beta; RNA Splicing; RNA, Messenger

Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic beta-Antagonists; Animals; Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Chlordiazepoxide; Darkness; Diazepam; Disease Models, Animal; Exploratory Behavior; Fenfluramine; Light; Male; Mice; Penbutolol; Propanolamines; Pyrimidines; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Receptor Agonists

Topics: Adrenal Glands; Adrenalectomy; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Amiloride; Animals; Blood; Blood Pressure; Brain Diseases; Central Nervous System Agents; Cisterna Magna; Disease Models, Animal; Diuretics; Dogs; Epinephrine; Extravascular Lung Water; Female; Hypertension, Pulmonary; Injections; Male; Propanolamines; Proteins; Pulmonary Alveoli; Pulmonary Artery; Pulmonary Edema; Sodium Channel Blockers; Veratrine

Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bacteremia; Capillary Permeability; Disease Models, Animal; Dopamine; Drug Evaluation, Preclinical; Escherichia coli Infections; Leukocytes; Male; Mesentery; Microcirculation; Propanolamines; Random Allocation; Rats; Rats, Wistar; Receptors, Adrenergic, beta-2; Vasodilator Agents

Topics: Adrenergic beta-Antagonists; Adult; Albuterol; Angiopoietin-1; Animals; Asthma; Bronchitis; Bronchodilator Agents; Capillary Permeability; Chronic Disease; Disease Models, Animal; Endothelial Growth Factors; Endothelium; Humans; Inflammation; Lung; Lymphokines; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Microcirculation; Nebulizers and Vaporizers; Neovascularization, Pathologic; Pneumonia, Mycoplasma; Propanolamines; Rats; Rats, Wistar; Research; Respiratory Mucosa; Salmeterol Xinafoate; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors